World Pharma News Digest - 07.12.2009

0 views
Skip to first unread message

Ruslan David

unread,
Dec 14, 2009, 3:43:42 AM12/14/09
to worldph...@googlegroups.com
GSK and Intercell form strategic alliance to develop and commercialise innovative vaccines 
GlaxoSmithKline Biologicals SA (GSK) and Intercell announced an agreement to form a strategic alliance to accelerate the development and commercialisation of needle-free, patch-based vaccines. The agreement will include Intercell's candidate vaccine for travellers' diarrhoea (TD) and an investigational single application pandemic influenza vaccine, as well as the use of the patch technology for other vaccines in GSK's portfolio. 
Read more... 
http://www.worldpharmanews.com/content/view/1056/1/
 
Pfizer Extends Commitment to Help Unemployed Americans 
Pfizer will extend its MAINTAINâ„¢ (Medicines Assistance for Those who Are in Need) patient assistance program for an additional year, through December 31, 2010. In addition to the more than 70 Pfizer primary care medicines currently available through MAINTAIN, Pfizer will extend the benefits of MAINTAIN to many legacy Wyeth medicines. 
Read more... 
http://www.worldpharmanews.com/content/view/1055/1/
 
Manhattan Research Releases Physician Digital Media Planning Guide 
While most marketers have accepted that nearly all physicians are online today, the more difficult part is figuring out where to find these physicians on the World Wide Web. Finding the right promotional mix for connecting with physicians can be a challenging proposition, as physicians use third-party sites - such as the WebMD Professional Network, the New England Journal of Medicine, or specialty specific sites - more frequently than they use pharma-owned properties. 
Read more... 
http://www.worldpharmanews.com/content/view/1054/1/
 
Physicians More Likely To Report Drug Safety Information Through Electronic Health Records System 
Pfizer announced today results of a survey the company recently sponsored that shows physicians are more likely to report side effects through an electronic health records (EHR) system, as compared to traditional paper methods. 
Read more... 
http://www.worldpharmanews.com/content/view/1053/1/
 
Novartis Tasigna® trial shows superior results to Glivec® 
In a large Phase III clinical trial, Tasigna® (nilotinib) demonstrated greater efficacy over Glivec® (imatinib)* in the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase[1]. 
Read more... 
http://www.worldpharmanews.com/content/view/1052/1/
 
Facet Biotech and Bristol-Myers Squibb Report Promising Phase I/II Interim Data for Elotuzumab 
Facet Biotech Corporation (Nasdaq: FACT) and Bristol-Myers Squibb Company (NYSE: BMY) announced that potentially promising data from a Phase I/II study of elotuzumab, an investigational humanized antibody being studied for the treatment of relapsed multiple myeloma (MM), were presented at the American Society of Hematology (ASH) 2009 Annual Meeting in New Orleans. 
Read more... 
http://www.worldpharmanews.com/content/view/1051/1/
 
Novo Nordisk starts phase 1 trial with oral insulin analogue 
Novo Nordisk has initiated its first phase 1 clinical trial with an oral insulin analogue (NN1952). This milestone releases a USD 2 million payment to Merrion Pharmaceuticals plc, whose GIPET® technology is used in the formulation of NN1952. 
Read more... 
http://www.worldpharmanews.com/content/view/1050/1/
 
PharmaNews.eu / Latest News
 
 
GSK initiates second pivotal Phase III trial for investigational cardiovascular medication Darapladib
http://www.pharmanews.eu/gsk/406-gsk-initiates-second-pivotal-phase-iii-trial-for-investigational-cardiovascular-medication-darapladib
 
 
Visanne® cleared for market launch in Europe as new treatment option for endometriosis
http://www.pharmanews.eu/bayer/404-visanner-cleared-for-market-launch-in-europe-as-new-treatment-option-for-endometriosis
 
Novartis receives approval in the European Union for Onbrez® Breezhaler®
http://www.pharmanews.eu/novartis/403-novartis-receives-approval-in-the-european-union-for-onbrezr-breezhalerr
 
European Medicines Agency advises of risk of fever in young children following vaccination with Pandemrix
http://www.pharmanews.eu/emea/402-european-medicines-agency-advises-of-risk-of-fever-in-young-children-following-vaccination-with-pandemrix
 
Bayer Team wins the "Deutscher Zukunftspreis" awarded by the German President
http://www.pharmanews.eu/bayer/401-bayer-team-wins-the-qdeutscher-zukunftspreisq-awarded-by-the-german-president
 
 
Bayer Schering Pharma to collaborate with Micromet on novel approach to cancer therapy
http://www.pharmanews.eu/bayer/399-bayer-schering-pharma-to-collaborate-with-micromet-on-novel-approach-to-cancer-therapy
 
European Commission tops a billion Euros invested in the fight against the global AIDS epidemic
http://www.pharmanews.eu/european-commission/398-european-commission-tops-a-billion-euros-invested-in-the-fight-against-the-global-aids-epidemic
 
With best regards,
Ruslan David, MD
Administrator/Editor
 
 
PS:
Subscribe to World Pharma News alerts by Email (a free service delivered by Google) -
http://feedburner.google.com/fb/a/mailverify?uri=worldpharmanews&loc=en_US
 
Subscribe to PharmaNews.eu alerts by Email (a free service delivered by Google) -
http://feedburner.google.com/fb/a/mailverify?uri=pharmanewseu&loc=en_US
Reply all
Reply to author
Forward
0 new messages